Determination of amiprilose in human plasma by high-performance liquid chromatography with fluorimetric detection.
A reversed-phase HPLC method to quantify amiprilose in human plasma is described. The method involves liquid-liquid extraction of amiprilose and the internal standard from plasma. The extracted compounds are derivatized with 1,8-naphthalic dicarboxylic acid using 2-chloro-1-methylpyridinium iodide as a coupling reagent. The derivatized products are separated on a reversed-phase column and monitored fluorimetrically using 280 nm and 340 nm as excitation and emission wavelengths, respectively. The derivatized products which exhibit two peaks on chromatogram, are shown to be the interconvertible isomers. This assay has been used in pharmacokinetic studies of amiprilose in humans.
Wu
S T
ST
The DuPont Merck Pharmaceutical Company, Drug Metabolism and Pharmacokinetics Section, Newark, DE 19714, USA.
Benet
L Z
LZ
Lin
E T
ET
D000276:Adjuvants, Immunologic / Q000097:blood* / Q000493:pharmacokinetics; D000998:Antiviral Agents / Q000097:blood* / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D006801:Humans; D007202:Indicators and Reagents; D009281:Naphthalenes; D011726:Pyridinium Compounds; D012266:Ribose / Q000031:analogs & derivatives; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D007202:Indicators and Reagents; D009281:Naphthalenes; D011726:Pyridinium Compounds; C048173:2-chloro-1-methylpyridinium; D012266:Ribose; D005944:Glucosamine; C018424:amiprilose; C073252:1,8-naphthalenedicarboxylic acid